Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression On Novel Hormonal Therapies Plus Avelumab
Previous studies have shown the benefit of immune-based therapies, such as sipuleucel-T, for Black men with metastatic prostate cancer. This study explored the